Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

STORY: Donald Trump says he will soon place a “small” tariff on imported drugs - but the levies won’t stay low for long.The U.S. president said Tuesday (August 5) that he would announce the duties for ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca ...

Vivani Medical Inc. (NASDAQ:VANI) on Tuesday reported results from the LIBERATE-1 Phase 1 study of the exenatide GLP-1 ...

The market report provides current cardiotoxicity treatment practices, emerging drugs, market share of individual therapies, ...

Operating expenses decreased sharply compared to Q2 2024, supporting a cash runway into the second quarter of 2026. - Dose expansion enrollment was completed for the lead product in its main clinical ...

Just days after telling AstraZeneca how proud he was at its $50 billion investment strategy for the US, President Donald ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a ...

President Trump on Thursday sent letters to 17 of the world’s biggest drugmakers demanding that they reduce some of their U.S ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...